Debora Jorn - Net Worth and Insider Trading

Debora Jorn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Debora Jorn owns 4 companies in total, including Viveve Medical Inc (VIVE) , Orexigen Therapeutics Inc (OREXQ) , and Bausch Health Companies Inc (BHC) among others .

Click here to see the complete history of Debora Jorn’s form 4 insider trades.

Insider Ownership Summary of Debora Jorn

Ticker	Comapny	Transaction Date	Type of Owner
VIVE	Viveve Medical Inc	2016-05-11	director
OREXQ	Orexigen Therapeutics Inc	2017-07-14	director
BHC	Bausch Health Companies Inc	2015-05-20	EVP & Company Group Chairman
		2017-06-27	EVP & Corp. & Comm'l Dev.

Debora Jorn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Debora Jorn Ownership Network

Ownership Network List of Debora Jorn

No Data

Ownership Network Relation of Debora Jorn

Debora Jorn Owned Company Details

What does Viveve Medical Inc do?

Who are the key executives at Viveve Medical Inc?

Debora Jorn is the director of Viveve Medical Inc. Other key executives at Viveve Medical Inc include 10 percent owner Goldman Sachs Group Inc , 10 percent owner Goldman Sachs & Co. Llc , and 10 percent owner Wilmot B. Harkey .

Viveve Medical Inc (VIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Viveve Medical Inc (VIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viveve Medical Inc (VIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Viveve Medical Inc (VIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viveve Medical Inc Insider Transactions

No Available Data

What does Orexigen Therapeutics Inc do?

Who are the key executives at Orexigen Therapeutics Inc?

Debora Jorn is the director of Orexigen Therapeutics Inc. Other key executives at Orexigen Therapeutics Inc include 10 percent owner Baupost Group Gp, L.l.c. , 10 percent owner Baupost Group Llc/ma , and 10 percent owner Seth A Klarman .

Orexigen Therapeutics Inc (OREXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orexigen Therapeutics Inc (OREXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orexigen Therapeutics Inc (OREXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orexigen Therapeutics Inc (OREXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orexigen Therapeutics Inc Insider Transactions

No Available Data

What does Bausch Health Companies Inc do?

Who are the key executives at Bausch Health Companies Inc?

Debora Jorn is the EVP & Company Group Chairman of Bausch Health Companies Inc. Other key executives at Bausch Health Companies Inc include EVP & General Counsel Seana Carson , SVP & Controller & CAO John S Barresi , and EVP & Chief Financial Officer Tom George Vadaketh .

Bausch Health Companies Inc (BHC) Insider Trades Summary

Over the past 18 months, Debora Jorn made no insider transaction in Bausch Health Companies Inc (BHC). Other recent insider transactions involving Bausch Health Companies Inc (BHC) include a net sale of 20,318 shares made by Seana Carson ,

In summary, during the past 3 months, insiders sold 13,370 shares of Bausch Health Companies Inc (BHC) in total and bought 0 shares, with a net sale of 13,370 shares. During the past 18 months, 20,318 shares of Bausch Health Companies Inc (BHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,318 shares.

Bausch Health Companies Inc (BHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bausch Health Companies Inc Insider Transactions

No Available Data

What does EyePoint Pharmaceuticals Inc do?

Who are the key executives at EyePoint Pharmaceuticals Inc?

Debora Jorn is the EVP & Corp. & Comm'l Dev. of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Medical Officer Dario A. Paggiarino .

EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary

Over the past 18 months, Debora Jorn made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .

In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 23,240 shares, with a net purchase of 23,240 shares. During the past 18 months, 4,229,811 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,486 shares.

EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

EyePoint Pharmaceuticals Inc Insider Transactions

No Available Data

Debora Jorn Mailing Address

Above is the net worth, insider trading, and ownership report for Debora Jorn. You might contact Debora Jorn via mailing address: 150 Commercial Street, Sunnyvale Ca 94086.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.